Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

September 16, 2021
Open Access

High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination

MedRxiv : the Preprint Server for Health Sciences
L. C. ShapiroR Alejandro Sica
September 16, 2021

Cancer immunotherapy: Recent advances and challenges.

Journal of Cancer Research and Therapeutics
Ruby DharSubhradip Karmakar
September 16, 2021

Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators.

ACS Medicinal Chemistry Letters
Flora W KimaniAaron P Esser-Kahn
September 16, 2021
Open Access

[Factors associated with scale-up human papillomavirus (HPV) vaccine in Senegal: a case-control survey of parents].

The Pan African Medical Journal
Mbouna NdiayeMamadou Makhtar Mbacke Leye
September 16, 2021
Open Access

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention.

Frontiers in Immunology
Lauren R CorulliMary L Disis
September 16, 2021

Immunization with a plasmid DNA vaccine encoding the N-terminus of Insulin like Growth Factor Binding Protein-2 in advanced ovarian cancer leads to high level Type I immune responses.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Denise L CecilMary L Disis
September 16, 2021

Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services.

The Journal of Laryngology and Otology
A K Abou-FoulA P George
September 16, 2021
Open Access

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis.

Cancer Cell International
Zicong YouFujun Shi
September 16, 2021

Engineered Attenuated Salmonella typhimurium Expressing Neoantigen Has Anticancer Effects.

ACS Synthetic Biology
Jungheun HyunDuhee Bang
September 16, 2021

Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth.

JAMA Network Open
Joseph NiyibiziHERITAGE Study Group
September 16, 2021

Detection of Unilateral Axillary Nodal Uptake Both at 68Ga-DOTATOC and 18F-FDG PET/CT After 1 Week From COVID-19 Vaccine.

Clinical Nuclear Medicine
Priscilla GuglielmoMichele Gregianin
September 16, 2021

Splenomegaly: Diagnosis and Management in Adults.

American Family Physician
Sommer Aldulaimi, Ana M Mendez
September 16, 2021

Inclusion criteria: how NK cells gain access to T cells.

The Journal of Clinical Investigation
Tonya J Webb
September 16, 2021

Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application.

American Journal of Cancer Research
Ziying HanHuayu Yang
September 16, 2021
Open Access

Women's Knowledge of Cervical Cancer: A cross-sectional study in Al Buraimi Governorate, Oman.

Sultan Qaboos University Medical Journal
Aisha N Al-SaadiEihab Dawi
September 16, 2021

PLK1 Inhibition Induces Immunogenic Cell Death and Enhances Immunity against NSCLC.

International Journal of Medical Sciences
Jie ZhouJing Cheng

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2021 Meta ULC. All rights reserved